Lumiliximab

Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses.
Read more
€0.00 (tax incl.)
Reference:
HY-P99303
Product Details
HY-P99303

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
COVID-19-immunoregulation
CAS
357613-86-6

Menu

Settings